Absci Corp

NASDAQ:ABSI   4:00:00 PM EDT
3.05
-0.31 (-9.23%)
7:13:51 PM EDT: $3.20 +0.15 (+4.92%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)281.79M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.73 Million
Adjusted EPS-$0.25
See more estimates
10-Day MA$3.17
50-Day MA$2.70
200-Day MA$3.35
See more pivots

Absci Corp Stock, NASDAQ:ABSI

18105 SE Mill Plain Boulevard, Suite 350, Vancouver, Washington 98683
United States of America
Phone: +1.360.949.1041
Number of Employees: 212

Description

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.